About this Journal Submit a Manuscript Table of Contents
Journal of Oncology
Volume 2013 (2013), Article ID 964863, 7 pages
http://dx.doi.org/10.1155/2013/964863
Research Article

Which Imaging Modality Is Superior for Prediction of Response to Neoadjuvant Chemotherapy in Patients with Triple Negative Breast Cancer?

1Department of Surgery, Washington University School of Medicine, 660 S. Euclid Avenue, Campus Box 8109, St. Louis, MO 63110, USA
2Department of Radiology, Washington University School of Medicine, St. Louis, MO 63110, USA
3Department of Surgery, University of Pennsylvania, Philadelphia, PA 19104, USA
4Division of Biostatistics, Washington University School of Medicine, St. Louis, MO 63110, USA

Received 25 October 2012; Revised 16 December 2012; Accepted 14 January 2013

Academic Editor: Gunter Von Minckwitz

Copyright © 2013 Jordan J. Atkins et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Jordan J. Atkins, Catherine M. Appleton, Carla S. Fisher, Feng Gao, and Julie A. Margenthaler, “Which Imaging Modality Is Superior for Prediction of Response to Neoadjuvant Chemotherapy in Patients with Triple Negative Breast Cancer?,” Journal of Oncology, vol. 2013, Article ID 964863, 7 pages, 2013. doi:10.1155/2013/964863